23 Dec, 12:19 - Indian

SENSEX 78556.59 (0.66)

Nifty 50 23769.30078125 (0.77)

Nifty Bank 51275.6484375 (1.02)

Nifty IT 43853.75 (0.19)

Nifty Midcap 100 57249.5 (0.60)

Nifty Next 50 69156.046875 (0.66)

Nifty Pharma 22618.400390625 (0.52)

Nifty Smallcap 100 18704.5 (-0.05)

23 Dec, 12:19 - Global

NIKKEI 225 39161.12 (1.19)

HANG SENG 19863.03 (0.72)

S&P 6041.25 (0.46)

Login/Signup
LOGIN HERE
Cancel

Sharda Cropchem Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 538666 | NSE Symbol : SHARDACROP | ISIN : INE221J01015 | Industry : Agro Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
17-Oct-2024 25-Oct-2024 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Meeting of Board of Directors is scheduled to be held on 25th October 2024 inter-alia to consider approve and take on record Unaudited Financial Result (Standalone and Consolidated) for quarter and half year ended 30th September 2024. The Board consider, approved and took on record Unaudited Financial Result (Standalone and Consolidated) for quarter and half year ended 30th September, 2024. Board consider, approved and took on record Unaudited Financial Result (Standalone and Consolidated) for quarter and half year ended 30th September, 2024 (As Per BSE Announcement Dated on 25.10.2024)
15-Jul-2024 23-Jul-2024 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 inter alia to consider and approve Board Meeting is scheduled to be held on 23 July 2024 to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter ending June 2024. The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2024 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter ended 30th June, 2024 is enclosed herewith The Board of Director considered approved and took on record the Unaudited Financial Result (Consolidated & Standalone) for quarter ending 30th June, 2024. (As per BSE Announcement Dated on 23/07/2024)
02-May-2024 10-May-2024 Final Dividend Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve As per the terms of Regulation 29 read with Regulation 47 of SEBI (LODR) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of our Company is scheduled to be held on Friday 10th May 2024 inter-alia to consider approve & take on record the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2024 and to consider & declare Dividend if any on the paid-up equity share capital of the Company for the Financial Year 2023-24. Further in continuation to our disclosure on Closure of Trading Window dated 30th March 2024 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till 12th May 2024. Our meeting started at 1:45 pm and concluded at 5:20 pm. The following matters were discussed: 1. The Audited Standalone and Audited Consolidated Financial Results of the Company for the financial year ended 31st March, 2024 is approved and the same are enclosed. 2. We hereby declare that in the Audit Report, accompanying the Annual Audited Standalone and Consolidated Financial Statements , the Statutory Auditors have not expressed any audit qualifications or other reservation and accordingly the Statement on impact of audit qualifications is not required to be given. 3. The Board of Directors considered and recommended dividend of Rs. 3.00 per equity share, subject to the approval of the shareholders at the forthcoming AGM of the Company. All other agenda items were approved in the meeting. The date of the forthcoming Annual General Meeting will be intimated in due course The Board of Directors of the Company has appointed Mr. H. S. Upendra Kamath (DIN: 02648119), Mr. Shalin S. Divatia (DIN: 00749517), and Mr. Vinod Kumar Kathuria (DIN: 06662559) as an Additional Director in the capacity of Non-Executive & Independent Director of the Company for an Initial term of 5 years from 10th May, 2024 to 09th May, 2029, not liable to retire by rotation, subject to approval of members in forthcoming Annual General Meeting of the Company (As per BSE Announcement Dated on 10/05/2024)
16-Jan-2024 24-Jan-2024 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve As per the terms of Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of our Company is scheduled to be held on Wednesday 24th January 2024 inter-alia to consider approve and take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2023. Further in continuation to our disclosure on Closure of Trading Window dated 30th December 2023 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till 26th January 2024. The Company has approved unaudited standalone & consolidated financials for the quarter and nine months ended 31st December, 2023 Results for quarter ended 31st December, 2023 (As Per BSE Announcement dated on 24.01.2024)
06-Dec-2023 06-Dec-2023 Change in Directors We would like to inform you that we have held the Board Meeting of our Company on Wednesday, 06th December, 2023 at 1:00 pm at our registered office. The meeting concluded at 03.45 pm and following matters were discussed: 1. Based on the recommendation of the NRC, the Board has considered and approved for conducting a Postal Ballot for obtaining Shareholders Approval for re-appointment of Ms. Sonal Desai (DIN: 08095343) as an Independent Director of the Company. 2. Based on the recommendation of the NRC and approval of the AC of the Company, the Board has considered and approved the appointment of Mr. Shailesh Anant Mehendale as CFO & KMP of the Company, w.e.f. 6th December, 2023. 3. Appointed Mr. Mayur D. Parmar, Proprietor of M/s. M D Parmar & Associates, PCS as Scrutinizer for conducting the e-voting process in a fair and transparent manner. The Company at its Board Meeting held today i.e. 6th December, 2023, appointed Mr. Shailesh Anant Mehendale as Chief Financial Officer & Key Managerial Personnel of the Company w.e.f. 6th December, 2023. We request you to take the same on record. The Company in its Board Meeting held today i.e. 6th December, 2023, approved the re-appointment of Ms. Sonal Desai as an Independent Director for a second term of 5 years from 1st April 2024 to 31st March, 2029, subject to approval of shareholders through Postal Ballot.
11-Oct-2023 21-Oct-2023 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2023 inter alia to consider and approve and take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2023. Further in continuation to our disclosure on Closure of Trading Window dated 29th September 2023 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till 24th October 2023. We request you to take the same on record. We would like to inform you that we have held the Board Meeting of our Company on Saturday, 21st October, 2023 at 1:00 pm at our registered office. The meeting concluded at 3:30 pm The following matters were discussed: The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter & half year ended 30th September, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter & half year ended 30th September, 2023 is enclosed herewith. All the other items of the Agenda were approved. We request you to take the same on record. The Board of Directors considered, approved and took on record the Unaudited Financial Results (standalone & consolidated) for the quarter and half year ended on 30th September 2023 pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015. (As Per BSE Announcement dated on 21.10.2023) Newspaper Advertisement of Unaudited Financial Results for the quarter and half year ended 30th September, 2023. (As Per BSE Announcement Dated on 25/10/2023)
13-Jul-2023 24-Jul-2023 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2023 inter alia to consider and approve & to take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2023. We would like to inform you that we have held the Board Meeting of our Company on Monday, 24th July, 2023 at 11.30 am at our registered office. The meeting concluded at 02.30 pm. The following matters were discussed: The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter ended 30th June, 2023 is enclosed herewith. All the other items of the Agenda were approved. We request you to take the same on record. The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2023 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 24/07/2023) Copy of Newspaper Advertisement of Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2023. (As Per BSE Announcement dated on 25.07.2023)
04-May-2023 12-May-2023 Accounts Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2023 inter alia to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2023 and to consider & declare Final Dividend if any on the paid-up equity share capital of the Company for the Financial Year 2022-23. Further in continuation to our disclosure on Closure of Trading Window dated 30th March 2023 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till 14th May 2023. We request you to take the same on record. We would like to inform you that our Board Meeting started at 11.30 am and concluded at 03.20 pm. The following matters were discussed: 1. The Board of Directors of the Company approved the Audited Standalone & Consolidated Financial Results of the Company for the financial year ended 31st March, 2023 and the same are enclosed herewith. 2. we hereby declare that the Statutory Auditors have not expressed any audit qualifications or other reservation and accordingly the Statement on impact of audit qualifications is not required to be given. 3. The Board of Directors considered and recommended Final Dividend at the rate of Rs. 3.00 per equity share of face value of Rs. 10.00 each for financial year 2022-23, subject to the approval of the shareholders at the forthcoming AGM of the Company. All other agenda items were approved in the meeting. (As Per BSE Announcement dated on 12.05.2023)
16-Jan-2023 24-Jan-2023 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2023 inter alia to consider and approve & take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter & nine months ended 31st December 2022 and to consider & declare Interim Dividend if any on the paid-up equity share capital of the Company for the Financial Year 2022-23. Further in continuation to our disclosure on Closure of Trading Window dated 31st December 2022 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till 26th January 2023. We would like to inform you that we have held the Board Meeting of our Company on Tuesday, 24th January 2023 at 11:30 am at our Registered Office. The meeting concluded at 2:30 pm.: 1. The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2022 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. A copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter and nine months ended 31st December, 2022 is enclosed herewith. 2. The Board of Directors considered and declared Interim Dividend at the rate of Rs. 3.00 per equity share. 3. The record date for the purpose of Interim Dividend will be Tuesday, 7th February, 2023. Dear Sir/Madam, We would like to inform you that we have held the Board Meeting of our Company on Tuesday, 24th January 2023 at 11:30 am at our Registered Office. The meeting concluded at 2:30 pm. The following matters were discussed: 1. The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter and nine months ended 31st December, 2022 is enclosed herewith. (As Per BSE Announcement Dated on 24.01.2023)
13-Oct-2022 21-Oct-2022 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2022 inter alia to consider and approve As per the terms of Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of our Company is scheduled to be held on Friday 21st October 2022 inter-alia to consider approve and take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2022. Further in continuation to our disclosure on Closure of Trading Window dated 30th September 2022 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till 23rd October 2022. We would like to inform you that we have held the Board Meeting of our Company on Friday, 21st October, 2022 at 11.30 am at our registered office. The meeting concluded at 2.00 pm. The following matters were discussed: The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter & half year ended 30th September, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter & half year ended 30th September, 2022 is enclosed herewith. (As per BSE Announcement Dated on 21/10/2022)
15-Jul-2022 25-Jul-2022 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 inter alia to consider and approve we wish to inform that the meeting of the Board of Directors of our Company is scheduled to be held on Monday 25th July 2022 inter-alia to consider approve and take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2022. Further in continuation to our disclosure on Closure of Trading Window dated 30th June 2022 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till 27th July 2022. We would like to inform you that we have held the Board Meeting of our Company on Monday, 25th July, 2022 at 11.00 am at our registered office. The meeting concluded at 1.15 pm. The following matters were discussed: The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter ended 30th June, 2022 is enclosed herewith. All the other items of the Agenda were approved. We request you to take the same on record. (As per BSE Announcement Dated on 25/07/2022)
04-May-2022 13-May-2022 Accounts Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2022 inter alia to consider and approve we wish to inform you that the meeting of the Board of Directors of our Company is scheduled to be held on Friday May 13th 2022 inter-alia to consider approve and take on record the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2022 & to consider and declare Final Dividend if any on the paid-up equity share capital of the Company for the Financial Year 2021-2022. Further in continuation to our disclosure on Closure of Trading Window dated March 31 2022 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till May 15 2022. The Board of Directors considered and recommended Final Dividend at the rate of Rs. 3.00 per equity share of face value of Rs. 10.00 each for Financial Year 2021-22, subject to the approval of the shareholders at the forthcoming Annual General Meeting of the Company. We would like to inform you that we have held the Board Meeting of our Company on Friday, 13th May, 2022 at 11:00 am through video conferencing. The meeting concluded at 2.15 pm. The following matters were discussed: 1. The Board of Directors of the Company have considered and approved the Audited Standalone Financial Results and Audited Consolidated Financial Results of the Company for the Financial Year ended 31st March, 2022 and the same are enclosed herewith. 2. we hereby declare that in the Audit Report, accompanying the Annual Audited Consolidated and Standalone Financial Statements of the Company for the Financial Year ended 31st March, 2022, the auditor has not expressed any Audit Qualifications or other reservation and accordingly the Statement on impact of Audit Qualifications is not required to be given. 3. The Board of Directors considered and recommended Final Dividend at the rate of Rs. 3.00 per equity share of face value of Rs. 10.00 each for Financial Year 2021-22. (As Per BSE Announcement dated on 13.05.2022) The Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2022 have been approved and taken on record by the Board of Directors in their meeting held on 13th May, 2022. The same was published in the following newspapers on 14th May, 2022:- 1) 'The Economic Times', Mumbai Edition, in English Newspaper; 2) 'Maharashtra Times', Mumbai Edition, in Marathi Newspaper. Please find enclosed the newspaper advertisement for your record. (As Per BSE Announcement dated on 16.05.2022)
13-Jan-2022 22-Jan-2022 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2022 inter alia to consider and approve We wish to inform you that the meeting of the Board of Directors of our Company is scheduled to be held on Saturday January 22 2022 inter-alia to consider approve & take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter & nine months ended December 31 2021 and to consider & declare Interim Dividend if any on the paid-up equity share capital of the Company for the Financial Year 2021-22. Further in continuation to our disclosure on Closure of Trading Window dated December 31 2021 pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading in the shares of the Company we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till January 24 2022. We would like to inform you that we have held the Board Meeting of our Company on Saturday, January 22, 2022 at 11:00 am through video conferencing. The meeting concluded at 1.00 pm. 1. The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021 pursuant to Regulation 33 of SEBI (LODR). A copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report from the Auditors for the quarter and nine months ended December 31, 2021 is enclosed herewith. 2. The Board of Directors considered and declared Interim Dividend at the rate of Rs. 3.00 per equity share of face value of Rs. 10.00 each for Financial Year 2021-22. We would like to inform you that we have held the Board Meeting of our Company on Saturday, January 22, 2022 at 11:00 am through video conferencing. The meeting concluded at 1.00 pm. The following matters were discussed: 1. The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. A copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report from the Auditors for the quarter and nine months ended December 31, 2021 is enclosed herewith. 2. The Board of Directors considered and declared Interim Dividend at the rate of Rs. 3.00 per equity share of face value of Rs. 10.00 each for Financial Year 2021-22. (As Per BSE Announcement Dated on 22.01.2022)
18-Oct-2021 26-Oct-2021 Quarterly Results Quarterly Results We would like to inform you that we have held the Board Meeting of our Company on Tuesday, October 26, 2021 at 11.30 am at our registered office. The meeting concluded at 1:30 pm. The following matters were discussed: The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report from the Auditors for the quarter and half year ended September 30, 2021 is enclosed herewith. All the other items of the Agenda were approved. (As per BSE Announcement Dated on 26/10/2021)
19-Jul-2021 27-Jul-2021 Quarterly Results Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve As per the terms of Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of our Company is scheduled to be held on Tuesday, July 27, 2021, inter-alia to consider, approve and take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter and three months ended June 30, 2021. Further, in continuation to our disclosure on Closure of Trading Window dated June 30, 2021, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading in the shares of the Company, we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till July 29, 2021. We request you to take the same on record. We would like to inform you that we have held the Board Meeting of our Company on Tuesday, 27th July, 2021 at 12.00 Noon at our registered office. The meeting concluded at 1:15 pm. The following matters were discussed: The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter ended June 30, 2021 is enclosed herewith. All the other items of the Agenda were approved The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the Unaudited Financial Results (Standalone & Consolidated) of the Company together with Limited Review Report (unmodified opinion) from the Auditors for the quarter ended June 30, 2021 is enclosed herewith. (As Per BSE Announcement Dated on 27.07.2021)
1 2